Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H47NO8 |
Molecular Weight | 525.6747 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]2(O[C@H]1[C@@H](C)C[C@@H](C)C(=O)\C=C\[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)C(=O)[C@@H]1C)O[C@H](C)C[C@@H]([C@H]2O)N(C)C
InChI
InChIKey=UZQBOFAUUTZOQE-VSLWXVDYSA-N
InChI=1S/C28H47NO8/c1-10-22-28(7,34)12-11-21(30)15(2)13-16(3)25(18(5)23(31)19(6)26(33)36-22)37-27-24(32)20(29(8)9)14-17(4)35-27/h11-12,15-20,22,24-25,27,32,34H,10,13-14H2,1-9H3/b12-11+/t15-,16+,17-,18+,19-,20+,22-,24-,25+,27+,28+/m1/s1
Molecular Formula | C28H47NO8 |
Molecular Weight | 525.6747 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/13123945Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/19027305 | https://www.ncbi.nlm.nih.gov/pubmed/14353806
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13123945
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/19027305 | https://www.ncbi.nlm.nih.gov/pubmed/14353806
Picromycin was studied by Brokmann and Hekel in 1951 and was the first antibiotic macrolide to be isolated. Picromycin is not a clinically useful antibiotic, it can be used as a raw material to synthesize antibiotic ketolide compounds such as ertythromycins and new epothilones. Picromycin is an antibiotic active mainly against gram-positive bacteria.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL347 Sources: https://www.ncbi.nlm.nih.gov/pubmed/13123945 |
|||
Target ID: CHEMBL356 Sources: https://www.ncbi.nlm.nih.gov/pubmed/13123945 |
|||
Target ID: CHEMBL360 Sources: https://www.ncbi.nlm.nih.gov/pubmed/13123945 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13123945
50 mg/kg daily for 7 days
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13123945
Picromycin weakly inhibited Streptococcus pneumoniae with MIC 0.1 ug/ml
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:08:03 GMT 2023
by
admin
on
Sat Dec 16 10:08:03 GMT 2023
|
Record UNII |
FBM8G3Z439
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8795
Created by
admin on Sat Dec 16 10:08:03 GMT 2023 , Edited by admin on Sat Dec 16 10:08:03 GMT 2023
|
PRIMARY | Merck Index | ||
|
Picromycin
Created by
admin on Sat Dec 16 10:08:03 GMT 2023 , Edited by admin on Sat Dec 16 10:08:03 GMT 2023
|
PRIMARY | |||
|
29665
Created by
admin on Sat Dec 16 10:08:03 GMT 2023 , Edited by admin on Sat Dec 16 10:08:03 GMT 2023
|
PRIMARY | |||
|
FBM8G3Z439
Created by
admin on Sat Dec 16 10:08:03 GMT 2023 , Edited by admin on Sat Dec 16 10:08:03 GMT 2023
|
PRIMARY | |||
|
19721-56-3
Created by
admin on Sat Dec 16 10:08:03 GMT 2023 , Edited by admin on Sat Dec 16 10:08:03 GMT 2023
|
PRIMARY | |||
|
DTXSID201026584
Created by
admin on Sat Dec 16 10:08:03 GMT 2023 , Edited by admin on Sat Dec 16 10:08:03 GMT 2023
|
PRIMARY | |||
|
5282037
Created by
admin on Sat Dec 16 10:08:03 GMT 2023 , Edited by admin on Sat Dec 16 10:08:03 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |